Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria

Oh, Jiwon; Barkhof, Frederik; Bar-Or, Amit; Ciccarrelli, Olga; Coetzee, Timothy; Filippi, Massimo; Granziera, Cristina; Hacohen, Yael; Hemmer, Bernhard; Kantarci, Orhun; Kim, Ho; Lebrun-Frenay, Christine; Montalban, Xavier; Mowry, Ellen; Ontaneda, Daniel; Prat, Alexandre; Reich, Daniel; Rovira, Àlex; Sati, Pascal; Siva, AKSEL; Solomon, Andrew; Sormani, Maria; Stankoff, Bruno; Thompson, Alan; Tintore, Mar; Traboulsee, Anthony; van der walt, Anneke; Wiendl, Heinz; Calabresi, Peter

doi:10.1038/s41591-026-04490-8

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria

Oh J., Barkhof F., Bar-Or A., Ciccarrelli O., Coetzee T., Filippi M., ...Daha Fazla

Nature Medicine, 2026 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Teknik Not
Basım Tarihi: 2026
Doi Numarası: 10.1038/s41591-026-04490-8
Dergi Adı: Nature Medicine
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, Chemical Abstracts Core, EMBASE, MEDLINE, Natural Science Collection (ProQuest), Biological Science Database (ProQuest), Health Research Premium Collection (ProQuest), Pharma Collection (ProQuest)
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

The 2024 revision of the McDonald diagnostic criteria is an important step toward earlier and more inclusive diagnosis of multiple sclerosis. Realizing its full potential will require continued refinement of biomarkers, disease stratification and clinical trial approaches.